Mint-Quetiapine 100 mg (Quetiapine (Quetiapine Fumarate) TABLET) 100 MG

Mint-Quetiapine 100 mg tablets are an oral medication used for managing certain mental health conditions. This generic formulation of quetiapine fumarate is manufactured by Mint Pharmaceuticals Inc. in Canada.

Strength

100 MG

Pack Size

10/100/500

Manufacturer / TM Owner

MINT PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mint-Quetiapine 100 mg tablets are commonly used to manage symptoms associated with mental health conditions. Quetiapine is often prescribed for conditions like schizophrenia and bipolar disorder. It works by affecting the balance of natural substances in the brain, helping to improve mood and behavior. What is Mint-Quetiapine used for? This medication is primarily used for its antipsychotic and mood-stabilizing properties.

Side Effects

Common effects of Mint-Quetiapine 100 mg tablets may include drowsiness, dizziness, and dry mouth. Some users might experience weight gain or changes in appetite. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

Mint-Quetiapine 100 mg tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid sudden discontinuation without medical advice. Store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Mint-Quetiapine 100 mg tablets may interact with certain substances, including alcohol and other medications that affect the central nervous system. It is advisable to consult a healthcare professional before combining this medication with other treatments. CYP inhibitors and inducers may also affect the metabolism of quetiapine.

Frequently Asked Questions

Mint-Quetiapine 100 mg tablets are used to manage symptoms associated with mental health conditions, such as schizophrenia and bipolar disorder.

Mint-Quetiapine 100 mg tablets are taken orally, typically as directed by a healthcare professional.

Common side effects may include drowsiness, dizziness, dry mouth, and weight gain.

It is important to consult a healthcare professional before combining Mint-Quetiapine with other medications.

Mint-Quetiapine is manufactured by Mint Pharmaceuticals Inc. in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.